
    
      PROTOCOL OUTLINE: This is a phase III study, lasting 3 years; 1996-1999. Patients are
      administered L-cysteine orally twice daily, 2 capsules with breakfast and 2 with lunch.

      Patients fill in questionnaires and diary sheets about their reaction to sunlight exposure,
      and have blood tested 3 times a year.

      Completion date provided represents the completion date of the grant per OOPD records
    
  